Inpharma Weekly

, Volume 1570, Issue 1, pp 18–18 | Cite as

Mifepristone provides clear QOL benefit in uterine leiomyoma

Clinical study

Keywords

Placebo Recipient Leiomyoma Study Endpoint Mifepristone Uterine Fibroid 

Copyright information

© Adis International Ltd 2007

Personalised recommendations